GlassScriptPhysician profile
Reagan M Wittek
NPI 1295817492
$1,215.98
in general payments reported to CMS, 2019-2025
25 companies · $313 in 2025
The $313 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $34.27 · 2021: $44.55 · 2022: $148 · 2023: $194 · 2024: $190 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $697.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $212.30 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $119.11 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $109.90 | 2019-2025 | Veozah |
| Pfizer INC. | $108.01 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $81.06 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.63 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $58.99 | 2023 | Myfembree |
| Exeltis, USA INC. | $58.27 | 2022-2025 | Slynd |
| Organon LLC | $48.30 | 2022-2025 | Nexplanon |
| Daiichi Sankyo INC. | $46.99 | 2019-2020 | |
| Coopersurgical, INC. | $43.80 | 2019-2025 | Ally II Ups, Paragard T 380a |
| Allergan, INC. | $30.62 | 2019 | |
| Hologic Sales and Service, LLC | $28.73 | 2019 | |
| Endo Pharmaceuticals INC. | $23.74 | 2019 | |
| Agile Therapeutics, INC. | $20.69 | 2023 | Twirla |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $19.65 | 2024 | |
| Millicent US INC | $18.22 | 2025 | Intrarosa, Femring |
| Medtronic, INC. | $16.71 | 2024 | Truclear |
| Ethicon US, LLC | $15.36 | 2022 | |
| Myovant Sciences INC. | $15.19 | 2021 | |
| Amag Pharmaceuticals, INC. | $14.47 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.00 | 2019 | |
| Avion Pharmaceuticals | $12.30 | 2022 | |
| Duchesnay USA Incorporated | $11.54 | 2019 | |
| Therapeuticsmd, INC. | $11.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reagan Wittek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.